At the meeting of The New Zealand Thyroid Association, held
on Saturday 04/10/09, we conducted a survey among those in
attendance regarding the health services they have used
since starting on GSK Eltroxin. These services are those
required to treat adverse reactions since the adoption of
the new formulation of GSK Eltroxin.
If you're using Scoop for work, your organisation needs to pay a small license fee with Scoop Pro. We think that's fair, because your organisation is benefiting from using our news resources. In return, we'll also give your team access to pro news tools and keep Scoop free for personal use, because public access to news is important!